Wednesday, 20 April 2016

MTS Recommends...

Impact from the Recent Issuance of ANVISA Resolution RDC-53/2015 on Pharmaceutical Small Molecule Forced Degradation Study Requirements

By Peter Tattersall, Suwimon Asawasiripong, Ivone Takenaka, and John A. Castoro
American Pharmaceutical Review, March 31, 2016

No comments:

Post a comment